TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11167372

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (200 microg, twice daily)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 9771300

Group type: EXPERIMENTAL
Intervention: Continuous extradural infusion of 0.125% bupivacaine 12.5 mg h‐1 and morphine 0.25 mg h‐1 (EXI group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA) with intravenous morphine (1 mg bolus, 5‐min lock‐out and maximum dose 20 mg 4h‐1)
Number of subjects: 60
Study: 7870743

Group type: EXPERIMENTAL
Intervention: Oxazepam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: WS 1490 (Kava-extract)
Number of subjects: 0
Study: 2246759

Group type: EXPERIMENTAL
Intervention: Prochlorperazine added to metoclopramide regimen
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine added to metoclopramide regimen
Number of subjects: 27
Study: 44671

Group type: EXPERIMENTAL
Intervention: Ordinary metoprolol tablets 0.1 g b.i.d.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Metoprolol slow-release tablets (Durules) 0.2 g once daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Metoprolol slow-release tablets (Durules)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ordinary metoprolol tablets
Number of subjects: 16
Study: 30209645

Group type: EXPERIMENTAL
Intervention: Tablet-based information communication technology early intervention application
Number of subjects: 59

Group type: COMPARATOR
Intervention: Therapy-as-usual
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: All participants pooled
Number of subjects: 59
Study: 28750975

Group type: EXPERIMENTAL
Intervention: Inter-trial intervals (ITI) of 1 second
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Inter-trial intervals (ITI) of 2 seconds
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Inter-trial intervals (ITI) of 3 seconds
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Inter-trial intervals (ITI) of 4 seconds
Number of subjects: 32
Study: 26242767

Group type: EXPERIMENTAL
Intervention: Insulin degludec/liraglutide (Xultophy®)
Number of subjects: 0
Study: 22549086

Group type: EXPERIMENTAL
Intervention: Electrical myostimulation (EMS)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Passive rest (PR)
Number of subjects: 19
Study: 20938195

Group type: EXPERIMENTAL
Intervention: Nonverbal auditory training for 2 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Untrained dyslexic subjects (control group)
Number of subjects: 40
Study: 19299356

Group type: EXPERIMENTAL
Intervention: Modified Mitchell's osteotomy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Original Mitchell method
Number of subjects: 60
Study: 17227978

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with 6 cycles of gemcitabine on days 1, 8, and 15 every 4 weeks (n = 179)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Observation (control) (n = 175)
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with gemcitabine
Number of subjects: 368

Group type: COMPARATOR
Intervention: Observation (control)
Number of subjects: 368
Study: 15472185

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1200 mg calcium carbonate)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 11216769

Group type: EXPERIMENTAL
Intervention: Bovine pericardial strips as a buttress along the lung staple line
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nonbuttressed staple line
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (nonbuttressed)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups (buttressed vs nonbuttressed)
Number of subjects: 80
Study: 7889010

Group type: EXPERIMENTAL
Intervention: Allogeneic bone marrow transplantation (BMT) from HLA-identical sibling
Number of subjects: 69

Group type: COMPARATOR
Intervention: Auto-BMT
Number of subjects: 69

Group type: COMPARATOR
Intervention: Maintenance chemotherapy
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Intensive antileukaemic therapy (vincristine, prednisone, daunorubicin, cyclophosphamide, Ara C, asparaginase)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 69
Study: 3605674

Group type: EXPERIMENTAL
Intervention: Caudal morphine (0.5 mg/ml, 0.1 mg/kg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Caudal bupivacaine (0.25%, 1 ml/kg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Intravenous morphine (control group)
Number of subjects: 46
Study: 29720489

Group type: EXPERIMENTAL
Intervention: Comprehensive postacute stroke intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 40
Study: 27306892

Group type: EXPERIMENTAL
Intervention: Blueberry powder (2 or 4 servings)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo powder
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Moderately high-fat breakfast (MHF)
Number of subjects: 23
Study: 25917552

Group type: EXPERIMENTAL
Intervention: GlideScope Cobalt Video laryngoscope
Number of subjects: 60

Group type: COMPARATOR
Intervention: Flexible fiberoptic bronchoscope
Number of subjects: 60
Study: 23129544

Group type: EXPERIMENTAL
Intervention: High-dose (HD) ablation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-dose (LD) ablation
Number of subjects: 60
Study: 21959624

Group type: EXPERIMENTAL
Intervention: OxyContin (Oxycodone) injections
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dexacort (Dexamethasone)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 18248104

Group type: EXPERIMENTAL
Intervention: 25% calorie restriction
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 12.5% calorie restriction and 12.5% increased energy expenditure by structured exercise
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low-calorie diet
Number of subjects: 48

Group type: COMPARATOR
Intervention: Healthy diet (no-calorie restriction)
Number of subjects: 48
Study: 16785214

Group type: EXPERIMENTAL
Intervention: Methadone treatment
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Buprenorphine treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control of craving
Number of subjects: 12
Study: 12592328

Group type: EXPERIMENTAL
Intervention: HuM195 at a dose of 12 mg/m(2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: HuM195 at a dose of 36 mg/m(2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: HuM195 (both doses)
Number of subjects: 50
Study: 10962963

Group type: EXPERIMENTAL
Intervention: Neutralised lignocaine-epinephrine (1%, 5 microgram/ml) with 1.0 ml sodium bicarbonate (8.4 g/l) added to 10 ml lignocaine-epinephrine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercially available lignocaine-epinephrine (pH 4.7)
Number of subjects: 0
Study: 24394578

Group type: EXPERIMENTAL
Intervention: 60mg iron, 500mg folic acid, 20,000 IU vitamin A, and 60mg vitamin C weekly for 5 weeks
Number of subjects: 84

Group type: COMPARATOR
Intervention: 60mg iron and 250mg folic acid weekly for 5 weeks
Number of subjects: 84
Study: 1335440

Group type: EXPERIMENTAL
Intervention: Propranolol (120 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 6464191

Group type: EXPERIMENTAL
Intervention: Oltipraz 1 X 25 mg/kg body weight
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Oltipraz 1 X 35 mg/kg body weight
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Oltipraz 2 X 20 mg/kg body weight
Number of subjects: 165

Group type: COMPARATOR
Intervention: Praziquantel 2 X 30 mg/kg body weight
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Oltipraz
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 165
Study: 30718072

Group type: EXPERIMENTAL
Intervention: Ramucirumab (8 mg/kg) plus cisplatin (80 mg/m2) and capecitabine (1000 mg/m2, twice daily for 14 days) every 21 days.
Number of subjects: 645

Group type: COMPARATOR
Intervention: Placebo plus cisplatin (80 mg/m2) and capecitabine (1000 mg/m2, twice daily for 14 days) every 21 days.
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Ramucirumab (8 mg/kg) plus cisplatin and capecitabine.
Number of subjects: 645

Group type: COMPARATOR
Intervention: Placebo plus cisplatin and capecitabine.
Number of subjects: 645
Study: 29935884

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation (CR) for 10 weeks (n=25)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Computer Game (CG) control for 10 weeks (n=24)
Number of subjects: 49
Study: 27131832

Group type: EXPERIMENTAL
Intervention: 4% menthol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Menthol (various concentrations: 0.04%, 0.4%, 1%, 2%, 4%, 7%, 8%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Menthol during PORH
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Menthol during local heating
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Menthol with sensory nerve inhibition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24947447

Group type: EXPERIMENTAL
Intervention: Brief alcohol consumption advice plus an information leaflet
Number of subjects: 1709

Group type: COMPARATOR
Intervention: Information leaflet alone
Number of subjects: 1709
Study: 21744028

Group type: COMPARATOR
Intervention: Dried cassava leaves at 0%, 20%, 40%, and 60% inclusion levels in diets
Number of subjects: 40
Study: 19951443

Group type: EXPERIMENTAL
Intervention: Intervention (reminder plus provider recommendation to call the Cancer Information Service and sample questions to ask)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care (routine colposcopy reminder letter)
Number of subjects: 0
Study: 17825001

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 15775795

Group type: EXPERIMENTAL
Intervention: Benazepril 20 mg once daily
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg once daily
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 12.5 mg once daily
Number of subjects: 64

Group type: COMPARATOR
Intervention: Amlodipine and Chlorthalidone compared to Benazepril
Number of subjects: 64
Study: 12175274

Group type: COMPARATOR
Intervention: PNCRM7 (PrevnarTM1) vaccine
Number of subjects: 211565
Study: 10067488

Group type: EXPERIMENTAL
Intervention: Tense category music
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Depressed category music
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Angry category music
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: All moods category music
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dance music
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Popular/independent music (associated with tense category)
Number of subjects: 12
Study: 7499013

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 41

Group type: COMPARATOR
Intervention: External landmark technique
Number of subjects: 41
Study: 2207950

Group type: EXPERIMENTAL
Intervention: Correspondence weight control program with weekly homework, interim weigh-ins, and participation deposits
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Correspondence weight control program with both homework and interim weigh-ins
Number of subjects: 142

Group type: COMPARATOR
Intervention: Correspondence weight control program
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Correspondence weight control program with both homework and weigh-ins
Number of subjects: 142
Study: 344085

Group type: EXPERIMENTAL
Intervention: Trancopal 400 mg
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 30790095

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 2350
Study: 28511688

Group type: EXPERIMENTAL
Intervention: Preconception supplements containing Folic Acid, Iron and Folic Acid (IFA), or Multiple Micronutrients
Number of subjects: 5011

Group type: EXPERIMENTAL
Intervention: Prenatal IFA supplements for daily consumption through delivery
Number of subjects: 5011

Group type: EXPERIMENTAL
Intervention: Preconception supplements
Number of subjects: 5011

Group type: EXPERIMENTAL
Intervention: Prenatal adherence
Number of subjects: 5011

Group type: EXPERIMENTAL
Intervention: Village health worker visits
Number of subjects: 5011
Study: 26856014

Group type: EXPERIMENTAL
Intervention: Experimental 1450 ppm fluoride as sodium monofluorophosphate (SMFP)/zinc‐based dentifrice
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Clinically proven 1450 ppm fluoride as SMFP/zinc‐based dentifrice (Positive Control)
Number of subjects: 14

Group type: COMPARATOR
Intervention: 1000 ppm fluoride as SMFP and 450 ppm fluoride as sodium fluoride (NaF) dentifrice (Negative Control)
Number of subjects: 14
Study: 23852814

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 9
Study: 21804439

Group type: COMPARATOR
Intervention: Manufacturers' guidelines (cases rinsed with multipurpose solution and air dried)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Alternative cleaning regimen (cases rubbed, rinsed with solution, tissue wiped, and air-dried face down)
Number of subjects: 40
Study: 19197204

Group type: EXPERIMENTAL
Intervention: Massage (40-minute myofascial induction)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (40-minute sham electrotherapy)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (Massage and Placebo)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 60
Study: 17178974

Group type: EXPERIMENTAL
Intervention: Nifedipine gastrointestinal therapeutic system (30 to 60 mg per day)
Number of subjects: 21
Study: 14644598

Group type: EXPERIMENTAL
Intervention: Cellulose membrane dressing (group 1)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Cellulose membrane dressing (group 3)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Unna boot (group 2)
Number of subjects: 3
Study: 11237488

Group type: COMPARATOR
Intervention: 5-day drainage
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 8-day drainage
Number of subjects: 121
Study: 9564200

Group type: EXPERIMENTAL
Intervention: Sertindole 24 mg/day
Number of subjects: 282

Group type: COMPARATOR
Intervention: Haloperidol 10 mg/day
Number of subjects: 282
Study: 8064705

Group type: EXPERIMENTAL
Intervention: Controlled-release, 10-mg pessary
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-dose gel, 2.5-mg doses
Number of subjects: 0
Study: 2663165

Group type: EXPERIMENTAL
Intervention: Piroxicam 0.5% gel
Number of subjects: 173

Group type: COMPARATOR
Intervention: Diclofenac 1.16% gel
Number of subjects: 173
Study: 31980016

Group type: EXPERIMENTAL
Intervention: ECOPIH users in the consolidation phase
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: ECOPIH users
Number of subjects: 289
Study: 31068954

Group type: EXPERIMENTAL
Intervention: COBRA therapy (prednisone 60 mg, methotrexate, sulfasalazine), n = 14
Number of subjects: 35

Group type: COMPARATOR
Intervention: COBRA-light therapy (prednisone 30 mg, methotrexate), n = 21
Number of subjects: 35
Study: 27353246

Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise group
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Aerobic exercise group
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study: 25986785

Group type: EXPERIMENTAL
Intervention: Recombinant human thrombopoietin
Number of subjects: 708

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 708
Study: 23507685

Group type: COMPARATOR
Intervention: Chlorhexidine mouthwash (SRP/CHX Gr‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Curcumin mouthwash (SRP/CUR Gr‐2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP Gr‐3)
Number of subjects: 30
Study: 20696480

Group type: EXPERIMENTAL
Intervention: Nurse-led intervention for treating depression
Number of subjects: 121

Group type: COMPARATOR
Intervention: Cognitive behaviour therapy (CBT) for preventing depression
Number of subjects: 121

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 121
Study: 19246907

Group type: EXPERIMENTAL
Intervention: Donepezil 10 mg/day
Number of subjects: 189
Study: 17523274

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) group
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (standard evaluation by consultant surgeon)
Number of subjects: 72
Study: 12701940

Group type: COMPARATOR
Intervention: Daily rhDNase
Number of subjects: 40

Group type: COMPARATOR
Intervention: Alternate day rhDNase
Number of subjects: 40
Study: 11171465

Group type: EXPERIMENTAL
Intervention: Propofol (target dose 5 micrograms.ml‐1 in 5 min)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Sevoflurane (8% tidal volume)
Number of subjects: 26
Study: 9172022

Group type: EXPERIMENTAL
Intervention: Ohmeda and Nellcor N200 with finger probe
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nellcor N200 with finger probe and N200 with C lock
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nellcor N200 with finger probe and Nellcor C Lock
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Criticare oximeter
Number of subjects: 8
Study: 7682268

Group type: EXPERIMENTAL
Intervention: Talc insufflation under thoracoscopic guidance
Number of subjects: 124

Group type: COMPARATOR
Intervention: Bleomycin
Number of subjects: 124

Group type: COMPARATOR
Intervention: Tetracycline
Number of subjects: 124
Study: 3467975

Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Citalopram 40 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Citalopram 40 mg (9 nights)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amitriptyline 75 mg (9 nights)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (9 nights)
Number of subjects: 12
Study: 29966024

Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed whey-based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Extensively hydrolyzed whey-based formula without short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (control)
Number of subjects: 41
Study: 27425567

Group type: EXPERIMENTAL
Intervention: Maytiv positive psychology school program
Number of subjects: 2517

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2517
Study: 25498035

Group type: EXPERIMENTAL
Intervention: Transradial approach (TRA)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Transfemoral approach (TFA)
Number of subjects: 49
Study: 22402304

Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 72

Group type: COMPARATOR
Intervention: Refraining from chewing gum
Number of subjects: 72
Study: 20580541

Group type: EXPERIMENTAL
Intervention: Low-dose arachidonic acid (80 mg ARA daily for 3 weeks)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 23
Study: 17981455

Group type: EXPERIMENTAL
Intervention: Diclofenac and paracetamol
Number of subjects: 78

Group type: COMPARATOR
Intervention: Paracetamol alone
Number of subjects: 78

Group type: COMPARATOR
Intervention: Diclofenac alone
Number of subjects: 78
Study: 16020567

Group type: EXPERIMENTAL
Intervention: Psychoeducation program
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 64
Study: 14725499

Group type: EXPERIMENTAL
Intervention: Group I (parent absent)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Group II (parent present)
Number of subjects: 200
Study: 10546925

Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 8

Group type: COMPARATOR
Intervention: Artemether with water
Number of subjects: 8
Study: 8740720

Group type: EXPERIMENTAL
Intervention: Vinorelbine 30 mg/m2 followed by Taxol 120 mg/m2 (V/T sequence)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Taxol 120 mg/m2 followed by Vinorelbine 30 mg/m2 (T/V sequence)
Number of subjects: 15
Study: 1930697

Group type: EXPERIMENTAL
Intervention: Plak Trac toothbrush
Number of subjects: 0

Group type: COMPARATOR
Intervention: Colgate ADA-approved manual toothbrush
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interplak toothbrush
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral B 35 manual brush
Number of subjects: 0
Study: 6127945

Group type: COMPARATOR
Intervention: Propranolol (240 mg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Verapamil (360 mg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 31521553

Group type: EXPERIMENTAL
Intervention: Physiotherapist advice and booklet about staying active during hospitalisation
Number of subjects: 68

Group type: COMPARATOR
Intervention: Usual hospital care
Number of subjects: 68
Study: 29728394

Group type: EXPERIMENTAL
Intervention: Genetically determined CETP concentration increase of 1 µg/mL
Number of subjects: 5706
Study: 26350543

Group type: EXPERIMENTAL
Intervention: Telemedicine (81 patients)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Control (97 patients)
Number of subjects: 178
Study: 24473774

Group type: EXPERIMENTAL
Intervention: Standard-risk acute lymphoblastic leukemia (SR-ALL) therapy
Number of subjects: 159
Study: 22496114

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1800

Group type: COMPARATOR
Intervention: PCI
Number of subjects: 1800
Study: 19946860

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 66

Group type: COMPARATOR
Intervention: Depot form of pre-randomisation drug
Number of subjects: 66
Study: 17877593

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 16244022

Group type: EXPERIMENTAL
Intervention: Small-dose (SD) bupivacaine (7.5 mg) with 5 mug of sufentanil
Number of subjects: 38

Group type: COMPARATOR
Intervention: Large-dose (LD) bupivacaine (12.5 mg) with 5 mug of sufentanil
Number of subjects: 38
Study: 12912857

Group type: EXPERIMENTAL
Intervention: Satiety drinking test in severely dyspeptic patients
Number of subjects: 62

Group type: COMPARATOR
Intervention: Satiety drinking test in controls
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Pharmacological agents (sumatriptan, cisapride, erythromycin)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Satiety drinking test overall
Number of subjects: 62